Centene’s Medicaid business and healthcare costs are problems, and the stock plunges - MarketWatch
1. Centene shares fell 39.8%, marking their worst trading day ever. 2. Company withdrew 2025 earnings guidance, citing high claim numbers and costs. 3. Mizuho analyst warns against buying until clarity on HIX costs emerges. 4. Competitors also suffered losses due to Centene's plummet. 5. Analysts are mostly neutral on Centene's future outlook.